Previous Close | 180.35 |
Open | 181.00 |
Bid | 181.63 x 1000 |
Ask | 181.66 x 800 |
Day's Range | 180.30 - 181.66 |
52 Week Range | 130.96 - 182.89 |
Volume | |
Avg. Volume | 5,680,991 |
Market Cap | 321.408B |
Beta (5Y Monthly) | 0.56 |
PE Ratio (TTM) | 66.74 |
EPS (TTM) | 2.72 |
Earnings Date | Apr 25, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | 6.20 (3.44%) |
Ex-Dividend Date | Apr 12, 2024 |
1y Target Est | 184.03 |
Subscribe to Yahoo Finance Plus to view Fair Value for ABBV
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.